April 2019 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link)  and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2018/19 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2022

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows: 

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Sole supply brand
(Supplier)

Date of subsidy change

Sole Subsidised Supply date

Clindamycin

Inj phosphate 150 mg per ml, 4 ml ampoule, 10 ampoule pack

$65.00

$39.00

Dalacin C
(Pfizer)

1 July 2019

1 October 2019

Levomepromazine maleate

Tab 25 mg, 100 tablet, blister pack

$16.93

$16.10

Nozinan
(Sanofi)

1 June 2019

1 September 2019

Levomepromazine maleate

Tab 100 mg, 100 tablet, blister pack

$43.96

$41.75

Nozinan
(Sanofi)

1 June 2019

1 September 2019

Omeprazole

Inj 40 mg ampoule with diluent, 5 glass ampoule pack

$33.98

$33.98

Dr Reddy’s Omeprazole
(Dr Reddy’s)

1 July 2019

1 October 2020 2019

Roxithromycin

Tab 150 mg, 50 tablet, blister pack

$7.48

$8.28

Arrow-Roxithromycin
(Teva)

1 June 2019

1 September 2019

Roxithromycin

Tab 300 mg, 50 tablet, blister pack

$14.40

$16.33

Arrow-Roxithromycin
(Teva)

1 June 2019

1 September 2019

Zoledronic acid

Inj 0.05 mg per ml, 100 ml, vial,
100 ml OP

$600.00

$60.00

Aclasta
(Novartis)

1 July 2019

1 October 2019

 2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Sole supply brand (Supplier)

Listing date

Sole Supply Status date

Brand (Supplier) affected by delisting

Amiodarone hydrochloride

Tab 100 mg, 30 tablet, blister pack

$4.66

$3.80

Aratac
(Mylan)

1 July 2019

1 December 2019

Cordarone-X
(Sanofi)

Amiodarone hydrochloride

Tab 200 mg, 30 tablet, blister pack

$7.63

$5.25

Aratac
(Mylan)

1 July 2019

1 December 2019

Cordarone-X
(Sanofi)

Cetomacrogol with glycerol

Crm 90% with glycerol 10%, 1,000 ml OP, bottle pack

$3.87

$3.10

Boucher
(Boucher)

1 October 2019

1 March 2020

Pharmacy Health Sorbolene with Glycerin
(API)

Cetomacrogol with glycerol

Crm 90% with glycerol 10%, 500 ml OP, bottle pack

$2.82

$2.35

Boucher
(Boucher)

1 October 2019

1 March 2020

Pharmacy Health Sorbolene with Glycerin
(API)

Clindamycin

Cap hydrochloride 150 mg, 24 capsule, blister pack

$4.10
(16 pack)

$4.61 (24 pack)

Dalacin C
(Pfizer)

1 November 2019

1 April 2020

Clindamycin ABM
(ABM)

Clopidogrel

Tab 75 mg, 84 tablet, blister pack

$5.44

$4.60

Clopidogrel Multichem (Multichem)

1 December 2019

1 May 2020

Arrow - Clopid
(Teva)

Levomepromazine hydrochloride

Inj 25 mg per ml, 1 ml ampoule, 10 ampoule pack

$47.89

$33.50

Nozinan
(Sanofi)

1 November 2019

1 April 2020

Wockhardt
(Max Health)

Lidocaine [lignocaine]

Gel 2%, 10 ml urethral syringe, 25 prefilled syringe pack

$160.00

$105.00

Cathejell
(InterPharma)

1 June 2019

1 November 2019

Pfizer (10 pack)
(Pfizer)

Ondansetron

Tab 4 mg, 50 tablet, blister pack

$3.36

$2.68

Onrex
(Rex Medical)

1 November 2019

1 April 2020

Apo-Ondansetron
(Apotex)

Ondansetron

Tab 8 mg, 50 tablet, blister pack

$4.77

$4.57

Onrex
(Rex Medical)

1 November 2019

1 April 2020

Apo-Ondansetron
(Apotex)

Sodium chloride

Inj 0.9%, 5 ml ampoule,
20 ampoule pack

$7.00
(50 pack)

$2.80 (20 pack)

Fresenius Kabi
(Fresenius Kabi)

1 July 2019

1 December 2019

InterPharma
(InterPharma)

Multichem
(Multichem)

Sodium chloride

Inj 0.9%, 10 ml ampoule,
50 ampoule pack

$6.63

$5.40

Fresenius Kabi
(Fresenius Kabi)

1 July 2019

1 December 2019

Pfizer
(Pfizer)

Sodium chloride

Inj 0.9%, 20 ml ampoule,
20 ampoule pack

$7.50
(30 pack)

$5.00
(20 pack)

$5.00

(20 pack)

Fresenius Kabi
(Fresenius Kabi)

1 July 2019

1 December 2019

InterPharma (30 pack)
(InterPharma)

Multichem (20 pack)
(Multichem)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Hospital supply brand
(Supplier)

DV
Limit

Listing date

Hospital Supply Status date

Cetomacrogol with glycerol

Crm 90% with glycerol 10%, 100 g tube

$3.20

$1.65

healthE
(Jaychem)

1%*

1 September 2019

1 December 2019

Clindamycin

Inj phosphate 150 mg per ml, 4 ml ampoule, 10 ampoule pack

$65.00

$39.00

Dalacin C
(Pfizer)

1%

1 July 2019

1 October 2019

Omeprazole

Inj 40 mg ampoule with diluent, 5 glass ampoule pack

$33.98

$33.98

Dr Reddy’s Omeprazole

(Dr Reddy’s)

1%

1 July 2019

1 October 2020  2019

Roxithromycin

Tab 150 mg, 50 tablet, blister pack

$7.48

$8.28

Arrow-Roxithromycin
(Teva)

1%

1 June 2019

1 September 2019

Roxithromycin

Tab 300 mg, 50 tablet, blister pack

$14.40

$16.33

Arrow-Roxithromycin
(Teva)

1%

1 June 2019

1 September 2019

Voriconazole1

Inj 200 mg vial, 1 vial pack

$65.00

$44.00

Neo Health
(Neo Health)

1%

1 July 2019

1 October 2019

Zoledronic acid

Inj 5 mg per 100 ml, vial, 1 vial pack

$600.00

$60.00

Aclasta
(Novartis)

1%

1 July 2019

1 October 2019

* The DV Limit applies to the pack sizes of 100 g or less.

1 The listed brand name of this product will be amended from Generic Partners to Neo Health.

4. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current price

New pack price

Hospital supply brand (Supplier)

DV
Limit

Listing date

Hospital Supply Status date

Brand (Supplier) affected by delisting

Amiodarone hydrochloride

Tab 100 mg, 30 tablet, blister pack

$4.66

$3.80

Aratac
(Mylan)

1%

1 July 2019

1 December 2019

Cordarone-X
(Sanofi)

Amiodarone hydrochloride

Tab 200 mg, 30 tablet, blister pack

$7.63

$5.25

Aratac
(Mylan)

1%

1 July 2019

1 December 2019

Cordarone-X
(Sanofi)

Cetomacrogol with glycerol

Crm 90% with glycerol 10%, 1,000 ml, bottle pack

$3.87

$3.10

Boucher
(Boucher)

1%*

1 October 2019

1 March 2020

Pharmacy Health Sorbolene with Glycerin
(API)

Cetomacrogol with glycerol

Crm 90% with glycerol 10%, 500 ml, bottle pack

$2.82

$2.35

Boucher
(Boucher)

1%*

1 October 2019

1 March 2020

Pharmacy Health Sorbolene with Glycerin
(API)

Clindamycin

Cap hydrochloride 150 mg, 24 capsule, blister pack

$4.10
(16 pack)

$4.61
(24 pack)

Dalacin C
(Pfizer)

1%

1 November 2019

1 April 2020

Clindamycin ABM
(ABM)

Clopidogrel

Tab 75 mg, 84 tablet, blister pack

$5.44

$4.60

Clopidogrel Multichem (Multichem)

1%

1 December 2019

1 May 2020

Arrow - Clopid
(Teva)

Levomepromazine hydrochloride

Inj 25 mg per ml, 1 ml ampoule, 10 ampoule pack

$47.89

$33.50

Nozinan
(Sanofi)

1%

1 November 2019

1 April 2020

Wockhardt
(Max Health)

Lidocaine [lignocaine] hydrochloride

Gel 2%, 10 ml urethral syringe, 25 prefilled syringe pack

$160.00

$105.00

Cathejell
(InterPharma)

1%

1 June 2019

1 November 2019

Pfizer (10 pack)
(Pfizer)

Ondansetron

Tab 4 mg, 50 tablet, blister pack

$3.36

$2.68

Onrex
(Rex Medical)

1%

1 November 2019

1 April 2020

Apo-Ondansetron
(Apotex)

Ondansetron

Tab 8 mg, 50 tablet, blister pack

$4.77

$4.57

Onrex
(Rex Medical)

1%

1 November 2019

1 April 2020

Apo-Ondansetron
(Apotex)

Sodium chloride

Inj 0.9%, 5 ml ampoule,
20 ampoule pack

$7.00
(50 pack)

$2.80
(20 pack)

Fresenius Kabi
(Fresenius Kabi)

1%

1 July 2019

1 December 2019

InterPharma
(InterPharma)

Sodium chloride

Inj 0.9%, 10 ml ampoule,
50 ampoule pack

$6.63

$5.40

Fresenius Kabi
(Fresenius Kabi)

1%

1 July 2019

1 December 2019

Pfizer
(Pfizer)

Sodium chloride

Inj 0.9%, 20 ml ampoule,
20 ampoule pack

$7.50 (30 pack)
$5.00 (20 pack)

$5.00
(20 pack)

Fresenius Kabi
(Fresenius Kabi)

1%

1 July 2019

1 December 2019

InterPharma (30 pack)
(InterPharma)

Multichem (20 pack)
(Multichem)

* DV Limit applies to pack sizes of greater than 100 g.

5. Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

New
pack price

Hospital supply brand
(Supplier)

DV
Limit

Listing date

Hospital Supply Status date

Levomepromazine

Tab 25 mg, 100 tablet, blister pack

$16.10

Nozinan
(Sanofi)

1%

1 June 2019

1 September 2019

Levomepromazine

Tab 100 mg, 100 tablet, blister pack

$41.75

Nozinan
(Sanofi)

1%

1 June 2019

1 September 2019

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2017/18 Invitation to Tender, dated 2 November 2017 and the 2018/19 Invitation to Tender, dated 1 November 2018.

2017/18 Invitation to Tender

Chemical name

Line item

Metaraminol tartrate

Inj 1 mg per ml, 1 ml

2018/19 Invitation to Tender

Chemical name

Line item

Albendazole

Tab

Amiloride with hydrochlorothiazide

Tab 5 mg with hydrochlorothiazide 50 mg

Benzoyl peroxide

Soln/Gel/Cream/Lotion 5%

Betaxolol hydrochloride

Eye drops 0.25%

Betaxolol hydrochloride

Eye drops 0.5%

Busulfan

Inj 6 mg per ml

Busulfan

Tab 2 mg

Caspofungin [whole market]

Inj 50 mg

Cefotaxime

Inj 500 mg

Chlorpromazine hydrochloride

Oral liq 100 mg per 5 ml

Dextrochlorpheniramine maleate

Oral liq 2 mg per 5 ml

Dextrochlorpheniramine maleate

Tab 2 mg

Diclofenac sodium

Tab 50 mg dispersible

Digoxin

Inj 250 mcg per ml, 2 ml

Doxycycline

Tab 20 mg - 50 mg

Haloperidol decanoate

Inj 50 mg per ml, 1 ml ampoule

Hydrogen peroxide

Soln 3% (10 vol)

Imipramine hydrochloride

Tab 10 mg

Imipramine hydrochloride

Tab 25 mg

Lorazepam

Inj 4 mg per ml, 1 ml

Magnesium Salt

Tab

Mexiletine

Cap 150 mg

Mexiletine

Cap 250 mg

Morphine sulphate

Tab long-acting 10 mg

Morphine sulphate

Tab long-acting 100 mg

Morphine sulphate

Tab long-acting 30 mg

Morphine sulphate

Tab long-acting 60 mg

Nitazoxanide

Tab 500 mg

Nystatin

Cap 500,000 u

Nystatin

Crm 100,000 u per g

Nystatin

Tab 500,000 u

Paper wasp venom

Inj 550 mcg vial with diluent

Paper wasp venom

Treatment kit - 6 vials 120 mcg freeze dried venom,
with diluent

Pimozide

Tab 2 mg or less

Pimozide

Tab 4 mg or more

Primidone

Tab 25 mg

Primidone

Tab 50 mg

Simeticone

Oral drops 100 mcg per ml

Sodium hyaluronate [hyaluronic acid]
with chondroitin sulphate

Inj 30 mg per ml with chondroitin sulphate 40 mg per
ml, 0.35 ml syringe and inj 10 mg sodium hyaluronate [hyaluronic acid] per ml, 0.4 ml syringe

Sodium hyaluronate [hyaluronic acid]
with chondroitin sulphate

Inj 30 mg per ml with chondroitin sulphate 40 mg per
ml, 0.5 ml syringe and inj 10 mg sodium hyaluronate [hyaluronic acid] per ml, 0.55 ml syringe

Sucralfate

Tab 1 g

Tetracycline

Cap 500 mg

Tetracycline

Tab 250 mg

Tobramycin

Eye drops 0.3%

Triazolam

Tab 125 mcg

Triazolam

Tab 250 mcg

Zinc

Oral liq 5 mg per 5 drops

Zuclopenthixol acetate

Inj 50mg per ml, 2 ml

For products included in the 2016/17, 2017/18 and 2018/19 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.